Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Atrion Co. stock logo
ATRI
Atrion
$459.92
$459.06
$274.98
$503.24
$809.46M0.6923,283 shsN/A
Cerus Corporation stock logo
CERS
Cerus
$1.45
-6.5%
$1.36
$1.12
$2.54
$277.18M1.561.33 million shs733,330 shs
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
$6.66
-1.8%
$6.51
$5.47
$10.14
$983.68M1.76685,569 shs652,029 shs
SiBone stock logo
SIBN
SiBone
$17.20
-8.4%
$18.17
$11.70
$20.05
$733.06M0.93393,559 shs382,421 shs
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$9.96
-2.9%
$10.16
$8.61
$21.10
$231.57M0.95251,785 shs132,387 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Atrion Co. stock logo
ATRI
Atrion
0.00%0.00%0.00%0.00%+1.33%
Cerus Corporation stock logo
CERS
Cerus
+4.03%+3.33%+7.64%+12.32%-17.11%
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
-2.59%+7.88%+3.83%-0.88%-1.02%
SiBone stock logo
SIBN
SiBone
+1.84%+1.73%-1.68%+40.46%+38.60%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
+1.28%-0.87%-0.87%-22.68%-10.78%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Atrion Co. stock logo
ATRI
Atrion
N/AN/AN/AN/AN/AN/AN/AN/A
Cerus Corporation stock logo
CERS
Cerus
3.2242 of 5 stars
3.54.00.00.02.71.70.6
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
3.9134 of 5 stars
3.53.00.00.02.83.31.9
SiBone stock logo
SIBN
SiBone
4.0611 of 5 stars
2.55.00.03.32.02.50.6
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
2.9781 of 5 stars
3.01.00.00.00.62.53.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Atrion Co. stock logo
ATRI
Atrion
0.00
N/AN/AN/A
Cerus Corporation stock logo
CERS
Cerus
3.00
Buy$3.50141.38% Upside
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
3.00
Buy$12.5087.69% Upside
SiBone stock logo
SIBN
SiBone
3.00
Buy$22.5030.81% Upside
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
2.00
Hold$16.0060.64% Upside

Current Analyst Ratings Breakdown

Latest ATRI, MDXG, SIBN, TCMD, and CERS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/7/2025
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
5/6/2025
SiBone stock logo
SIBN
SiBone
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$20.00 ➝ $22.00
5/6/2025
SiBone stock logo
SIBN
SiBone
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$25.00 ➝ $25.00
5/6/2025
SiBone stock logo
SIBN
SiBone
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$24.00 ➝ $24.00
5/6/2025
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Neutral$25.00 ➝ $14.00
(Data available from 7/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Atrion Co. stock logo
ATRI
Atrion
$181.60M4.46$19.68 per share23.37$138.02 per share3.33
Cerus Corporation stock logo
CERS
Cerus
$185.14M1.50N/AN/A$0.31 per share4.68
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
$348.88M2.82$0.32 per share21.01$1.31 per share5.08
SiBone stock logo
SIBN
SiBone
$167.18M4.38N/AN/A$3.98 per share4.32
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$292.98M0.79$1.06 per share9.36$9.03 per share1.10
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Atrion Co. stock logo
ATRI
Atrion
$19.41M$10.6443.23N/A10.60%7.75%7.12%N/A
Cerus Corporation stock logo
CERS
Cerus
-$20.92M-$0.10N/AN/AN/A-10.23%-34.81%-9.68%7/30/2025 (Estimated)
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
$42.42M$0.2724.6720.81N/A11.40%22.70%16.77%7/30/2025 (Estimated)
SiBone stock logo
SIBN
SiBone
-$30.91M-$0.64N/AN/AN/A-15.03%-16.00%-11.69%8/4/2025 (Estimated)
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$16.96M$0.6615.0911.86N/A5.52%8.41%6.10%8/4/2025 (Estimated)

Latest ATRI, MDXG, SIBN, TCMD, and CERS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/4/2025Q2 2025
SiBone stock logo
SIBN
SiBone
-$0.19N/AN/AN/A$48.12 millionN/A
8/4/2025Q2 2025
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$0.09N/AN/AN/A$73.93 millionN/A
7/30/2025Q2 2025
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
$0.06N/AN/AN/A$90.79 millionN/A
5/5/2025Q1 2025
SiBone stock logo
SIBN
SiBone
-$0.24-$0.15+$0.09-$0.15$45.13 million$47.29 million
5/5/2025Q1 2025
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
-$0.07-$0.13-$0.06-$0.13$63.48 million$61.27 million
5/1/2025Q1 2025
Cerus Corporation stock logo
CERS
Cerus
-$0.05-$0.04+$0.01-$0.04$47.44 million$43.24 million
4/30/2025Q1 2025
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
$0.06$0.06N/A$0.05$86.32 million$88.21 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Atrion Co. stock logo
ATRI
Atrion
$8.801.91%N/A82.71%21 Years
Cerus Corporation stock logo
CERS
Cerus
N/AN/AN/AN/AN/A
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
N/AN/AN/AN/AN/A
SiBone stock logo
SIBN
SiBone
N/AN/AN/AN/AN/A
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Atrion Co. stock logo
ATRI
Atrion
N/A
9.18
3.06
Cerus Corporation stock logo
CERS
Cerus
1.15
2.32
1.63
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
0.09
4.70
4.13
SiBone stock logo
SIBN
SiBone
0.21
8.53
7.26
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
0.11
4.52
3.99

Institutional Ownership

CompanyInstitutional Ownership
Atrion Co. stock logo
ATRI
Atrion
66.19%
Cerus Corporation stock logo
CERS
Cerus
78.37%
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
79.15%
SiBone stock logo
SIBN
SiBone
98.11%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
83.43%

Insider Ownership

CompanyInsider Ownership
Atrion Co. stock logo
ATRI
Atrion
22.82%
Cerus Corporation stock logo
CERS
Cerus
5.60%
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
1.70%
SiBone stock logo
SIBN
SiBone
4.00%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
2.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Atrion Co. stock logo
ATRI
Atrion
7201.76 million1.36 millionNot Optionable
Cerus Corporation stock logo
CERS
Cerus
290191.16 million180.46 millionOptionable
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
870147.70 million145.19 millionOptionable
SiBone stock logo
SIBN
SiBone
35042.62 million40.91 millionOptionable
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
1,03723.25 million22.67 millionOptionable

Recent News About These Companies

Tactile Systems stock tumbles after Q1 miss

New MarketBeat Followers Over Time

Media Sentiment Over Time

Atrion stock logo

Atrion NASDAQ:ATRI

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Cerus stock logo

Cerus NASDAQ:CERS

$1.45 -0.10 (-6.45%)
Closing price 04:00 PM Eastern
Extended Trading
$1.45 0.00 (0.00%)
As of 06:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation was incorporated in 1991 and is headquartered in Concord, California.

MiMedx Group stock logo

MiMedx Group NASDAQ:MDXG

$6.66 -0.12 (-1.77%)
Closing price 04:00 PM Eastern
Extended Trading
$6.66 0.00 (-0.08%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia.

SiBone stock logo

SiBone NASDAQ:SIBN

$17.20 -1.58 (-8.41%)
Closing price 04:00 PM Eastern
Extended Trading
$17.20 0.00 (0.00%)
As of 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Tactile Systems Technology stock logo

Tactile Systems Technology NASDAQ:TCMD

$9.96 -0.30 (-2.92%)
Closing price 04:00 PM Eastern
Extended Trading
$9.99 +0.03 (+0.35%)
As of 05:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.